{
    "clinical_study": {
        "@rank": "144613", 
        "brief_summary": {
            "textblock": "Monocentric prospective study conducted in two phases evaluating the secretion and\n      elimination of aqueous humor by fluorophotometry in patients with glaucoma treated with\n      cyclo-coagulation with ultrasound.\n\n      Population selected:\n\n      - Patients with refractory open angle glaucoma despite previous treatments currently\n      validated for glaucoma.\n\n      The purpose of our study is:\n\n      - To evaluate the mechanism of action of glaucoma treatment by cyclo-coagulation with high\n      intensity focused ultrasound in studying the secretion and elimination of aqueous humor by\n      fluorophotometry.\n\n      Planning:\n\n        -  First phase: 2 patients (feasibility study) If reduction of at least 10% of the flow of\n           aqueous humor production at one month in the first two patients in the feasibility\n           study, further in second phase.\n\n        -  Second phase: 6 patients"
        }, 
        "brief_title": "Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).", 
        "condition": "Refractory Open Angle Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "detailed_description": {
            "textblock": "Main outcome criteria:\n\n      Reduction of aqueous humor flow at 6 months compared with the pretreatment of aqueous humor\n      flow."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  refractory primary open-angle glaucoma (POAG)\n\n          -  IOP> 21 mm Hg and <32 mm Hg with an optimal treatment.\n\n          -  Lack of history of cyclo-destruction of the ciliary body (laser diode, cold ...)\n\n          -  Lack of intraocular surgery or laser therapy in the eye seen in the three months\n             preceding the date of HIFU treatment.\n\n          -  Male or female age (s) of at least 18 and able to give informed consent\n\n          -  Patient who signed the informed consent form\n\n          -  Patient affiliated to a social security scheme\n\n        Exclusion Criteria:\n\n          -  History of glaucoma by placing a drainage implant (valves, pipes ...)\n\n          -  previous refractive procedures preventing accurate measurement of intraocular\n             pressure (PRK, LASIK)\n\n          -  General treatment which may alter IOP began in the month before the HIFU procedure\n\n          -  Patient monophthalmus\n\n          -  thyroid orbitopathy\n\n          -  History of ocular or retrobulbar tumor\n\n          -  Cyclodialysis\n\n          -  choroidal hematoma or uprising choroidal\n\n          -  Anatomy of the eyeball inadequate treatment or medical device (eye too small or too\n             large)\n\n          -  Pregnancy, breastfeeding, lack of contraceptive use among women at risk of having a\n             child\n\n          -  Participation in another clinical investigation of a medical or surgical treatment\n             can affect the intraocular pressure in the three months preceding the HIFU\n\n          -  Patient minor or major protected by law"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "July 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01908985", 
            "org_study_id": "EYEMUST-FLUO"
        }, 
        "intervention": {
            "intervention_name": "high intensity focused ultrasound for cyclodestruction in the eye", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "glaucoma", 
            "high intensity focused ultrasound", 
            "aqueous humor", 
            "fluorophotometry"
        ], 
        "lastchanged_date": "July 24, 2013", 
        "official_title": "Ocular Fluorophotometry to Assess the Aqueous Humor Production for Patients With Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).", 
        "overall_contact": {
            "email": "fchiambaretta@chu-clermontferrand.fr", 
            "last_name": "Frederic Chiambaretta, PhD", 
            "phone": "+33 (0)4 73 75 14 67"
        }, 
        "overall_status": "Available", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ]
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01908985"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "EyeTechCare", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EyeTechCare", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "July 2013"
    }
}